Pearl Cohen successfully represented client, Hill-Rom (NYSE: HRC), in a $30 million IP Assets acquisition and Licensing transaction. Additional consideration comprises of earn out payments and the transfer back to EarlySense of its shares. Since 1915, Hillrom has become a global leader in medical technology, enhancing outcomes for patients and their caregivers. Its acquisition of EarlySense's contact-free continuous monitoring technology will aim to provide caregivers with a full picture of patient health, allowing for intervention at the earliest signs of patient deterioration.

Hill-Rom was represented bySenior Partners, Mark Cohen, Hili Rashkovan, and Dr. Tal Rotman and Partner, Dr. Maya Lakstein. See full article here: